Cargando…
Synergistic drug combinations designed to fully suppress SARS-CoV-2 in the lung of COVID-19 patients
Despite new antivirals are being approved against SARS-CoV-2 they suffer from significant constraints and are not indicated for hospitalized patients, who are left with few antiviral options. Repurposed drugs have previously shown controversial clinical results and it remains difficult to understand...
| Autores principales: | , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Public Library of Science
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9648746/ https://www.ncbi.nlm.nih.gov/pubmed/36355808 http://dx.doi.org/10.1371/journal.pone.0276751 |